Bilateral subcutaneous synergic mouse tumour model with intra-tumoural OV injection:Survival: significantly prolonged survival compared to parental OV and untreatedDisease control: significantly decreased tumour growth compared to parental OV and untreatedImmune response: significantly increased tumour CD8+ T cell infiltration compared to parental OV. The gene discussed is CD8A; the disease is neoplasm.